Q3'FY24 Revenue at Rs. 449 crores is up by 28% on a y-o-y basis. 9M revenue of Rs. 1277 crores, is up 21%.
API total revenue at Rs. 253 Crores for Q3 is up by 20% on a y-o-y basis, whereas for a 9M period at Rs. 668 Crores
Q3 revenue for the Formulation business at Rs. 65 crores is up by 40% whereas, for 9 months period, revenue growth is at 22% for Rs. 166 Crores
Domestic revenue for the Q3 at Rs. 271 crores is up by 27%. For the 9M period, at Rs. 829 Crores, revenue growth is at 30%
Revenues growth is at 10%. API Q3 exports at Rs. 176 Crores are up by 31% while Domestic Business is up only 1%.
The medical devices business continues its high growth journey with 24% revenue growth in Q3 and a 37% jump in the 9M period.
Q3'FY24 Revenue at Rs. 449 crores is up by 28% on a y-o-y basis. 9M revenue of Rs. 1277 crores, is up 21%.
Domestic revenue for the Q3 at Rs. 271 crores is up by 27%. For the 9M period, at Rs. 829 Crores, revenue growth is at 30%
API total revenue at Rs. 253 Crores for Q3 is up by 20% on a y-o-y basis, whereas for a 9M period at Rs. 668 Crores
Revenues growth is at 10%. API Q3 exports at Rs. 176 Crores are up by 31% while Domestic Business is up only 1%.
Q3 revenue for the Formulation business at Rs. 65 crores is up by 40% whereas, for 9 months period, revenue growth is at 22% for Rs. 166 Crores
The medical devices business continues its high growth journey with 24% revenue growth in Q3 and a 37% jump in the 9M period.
Morepen - The Future of Home Diagnostics and OTC Health Products
India Pharma Outlook
Dr. Morepen launches advanced Muscle Food to fuel your performance
The Pharma Times
Dr. Morepen launches advanced Pre-workout Muscle Food to fuel your performance
Business Gujarat News
Empowering Health. Everywhere
Morepen is dedicated to providing affordable, high-quality healthcare solutions through innovative pharmaceutical and medical technology products. We strive to make health accessible for all and achieve a global reach.
Excellence. Passion. Action. Innovation
Morepen is driven by a commitment to excellence in everything we do. Our three core values – Passion, Action, and Innovation – guide our actions. We prioritize delivering superior quality products, efficient distribution networks, and exceptional customer service. We are a passionate and results-oriented team, leveraging technology for continuous research and development. Our goal is to remain at the forefront of healthcare solutions.
Annual Return
Annual Secretarial Compliance Report
Newspaper Advertisements
Investor Earning CallQ3 FY 2024
